Truist upgraded pain therapy developer Pacira BioSciences (NASDAQ:PCRX) to Hold from Sell on Thursday, noting that the ...

Truist Securities adjusted its outlook on Manpower Inc . (NYSE:MAN), reducing the staffing company's price target from $74.00 to $70.00. Despite this change, the firm maintained its Hold rating on the ...

This was the stock's second consecutive day of gains.

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...

Truist Financial analyst Michael Roxland reiterated a Buy rating on Silgan Holdings (SLGN – Research Report) today and set a price target of ...

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...

Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.

Net interest margin, which measures lending profitability, expanded to 3.07%, compared with 2.95% a year earlier. Truist's ...

Truist Financial Corp. continued to settle into its trimmer fee-income strategy during the fourth quarter by slightly ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...